Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
28.19
+1.32 (4.91%)
At close: Feb 24, 2026, 4:00 PM EST
28.75
+0.56 (1.99%)
After-hours: Feb 24, 2026, 7:38 PM EST

HRMY Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,6242,1551,9621,8923,2682,493
Market Cap Growth
-23.98%9.83%3.73%-42.12%31.09%21.23%
Enterprise Value
1,0121,6521,7371,7213,1552,496
Last Close Price
28.1937.4234.4132.3055.1042.64
PE Ratio
10.4013.5813.4914.6818.0172.07
Forward PE
8.1210.0511.8211.1423.0125.27
PS Ratio
1.872.482.753.257.478.16
PB Ratio
1.872.482.984.058.1113.37
P/TBV Ratio
2.082.763.605.7413.5158.54
P/FCF Ratio
4.676.208.988.6422.6525.37
P/OCF Ratio
4.666.198.938.6222.6225.30
PEG Ratio
0.440.390.470.73--
EV/Sales Ratio
1.171.902.432.967.218.17
EV/EBITDA Ratio
4.337.078.087.9521.9823.46
EV/EBIT Ratio
4.857.939.108.9626.2528.51
EV/FCF Ratio
2.914.757.957.8621.8725.40
Debt / Equity Ratio
0.190.190.280.420.481.05
Debt / EBITDA Ratio
0.700.700.840.901.341.82
Debt / FCF Ratio
0.470.470.830.901.351.99
Net Debt / Equity Ratio
-0.70-0.70-0.43-0.34-0.32-0.21
Net Debt / EBITDA Ratio
-2.62-2.62-1.33-0.73-0.90-0.36
Net Debt / FCF Ratio
-1.76-1.76-1.31-0.72-0.89-0.39
Asset Turnover
0.770.770.790.780.790.71
Inventory Turnover
31.6031.6024.9725.1019.1313.45
Quick Ratio
3.463.463.142.614.795.01
Current Ratio
3.603.603.312.755.075.29
Return on Equity (ROE)
20.75%20.75%25.84%29.63%61.58%24.39%
Return on Assets (ROA)
11.47%11.47%13.17%16.16%13.57%12.71%
Return on Invested Capital (ROIC)
52.07%48.68%42.39%48.91%56.97%76.78%
Return on Capital Employed (ROCE)
20.40%20.40%23.20%29.60%20.20%23.10%
Earnings Yield
9.77%7.36%7.41%6.81%5.55%1.39%
FCF Yield
21.43%16.14%11.14%11.58%4.42%3.94%
Buyback Yield / Dilution
-1.17%-1.17%4.15%1.19%-3.19%-129.72%
Updated Feb 24, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q